SCHEMBL28048561

SCHEMBL28048561

NC(CC(=O)O)C(Cl)c1cc(F)c(F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 2/20 0.33
DPP4 P27487 3/20 0.32
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
MEN1 O00255 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP3A4 P08684 1/20 0.30
EEF2K O00418 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743074 0.80 DPP4 (0.39) FFAR1DPP4SLC1A3SLC1A2SLC1A1
SCHEMBL743043 0.80 DPP4 (0.39) FFAR1DPP4SLC1A3SLC1A2SLC1A1
SCHEMBL12971465 0.80 DPP4 (0.39) FFAR1DPP4SLC1A3SLC1A2SLC1A1
SCHEMBL744345 0.80 DPP4 (0.39) FFAR1DPP4SLC1A3SLC1A2SLC1A1
SCHEMBL3795621 0.74 DPP4 (0.34) FFAR1DPP4CYP2C19
SCHEMBL28304220 0.73 DPP4 (0.33) FFAR1DPP4SLC1A3SLC1A2SLC1A1
SCHEMBL28937621 0.72 FFAR1 (0.33) FFAR1DPP4SLC1A3SLC1A2SLC1A1
SCHEMBL3453796 0.71 DPP4 (0.37) FFAR1DPP4
SCHEMBL28696572 0.70 S1PR2 (0.38) FFAR1DPP4CYP3A4
SCHEMBL5084398 0.69 EIF4A3 (0.34) SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105254519-B Synthesizing method of sitagliptin key intermediate 常州吉恩药业有限公司 2017-05-17 CN disclosed
CN-105254519-B Synthesizing method of sitagliptin key intermediate 常州吉恩药业有限公司 2017-05-17 CN disclosed
CN-105254519-A Synthesizing method of sitagliptin key intermediate GENCHEM & GENPHARM CHANGZHOU CO LTD 2016-01-20 CN disclosed